Analyst Ratings For Acasti Pharma Inc (NASDAQ:ACST)

Today, HC Wainwright initiated coverage on Acasti Pharma Inc (NASDAQ:ACST) with a Buy with a price target of $6.00.

There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on Acasti Pharma Inc (NASDAQ:ACST) is Buy with a consensus target price of $6.00 per share, a potential 471.43% upside.

Some recent analyst ratings include

• 6/26/2019-Acasti Pharma Inc (NASDAQ:ACST) has coverage initiated with a Buy rating and $6.00 price target
• 1/29/2018-Acasti Pharma Inc (NASDAQ:ACST) had its Buy rating reiterated by Dawson James
• 1/5/2018-Acasti Pharma Inc (NASDAQ:ACST) has coverage initiated with a Buy rating and $7.00 price target

Recent Trading Activity for Acasti Pharma Inc (NASDAQ:ACST)
Shares of Acasti Pharma Inc closed the previous trading session at 1.05 up +0.040 3.96% with 3025400 shares trading hands.